Egalet

About:

Egalet is a specialty pharmaceutical company that develops pain management products.

Website: http://www.egalet.com

Twitter/X: egaletcorp

Top Investors: Index Ventures, Atlas Venture, Omega Funds, Danske Bank, Sunstone Life Science Ventures

Description:

Egalet is a specialty pharmaceutical company that develops pain management products. The company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.

Total Funding Amount:

$115M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Wayne, Pennsylvania, United States

Founded Date:

1995-01-01

Contact Email:

info(AT)egalet.com

Founders:

Jan Quistgaard

Number of Employees:

51-100

Last Funding Date:

2016-09-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai